These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 28145863)
1. The association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome. Gu HF; Mou M; Liang ZG; Sun C; Ren XY; Xiao YB Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):44-47. PubMed ID: 28145863 [TBL] [Abstract][Full Text] [Related]
2. Association of Paraoxonase 1 Gene Polymorphisms and Polycystic Ovarian Syndrome Susceptibility: A Systematic Review and Meta-Analysis. Jiang X; Ding C; Wang C; Yu J; Hua Z; Chen X; Ma J; Chen W Gynecol Obstet Invest; 2020; 85(2):167-177. PubMed ID: 32114577 [TBL] [Abstract][Full Text] [Related]
3. PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome. Dadachanji R; Shaikh N; Khavale S; Patil A; Shah N; Mukherjee S Fertil Steril; 2015 Jul; 104(1):207-16. PubMed ID: 25956367 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis. Liu C; Liu L Tumour Biol; 2011 Dec; 32(6):1233-40. PubMed ID: 21887553 [TBL] [Abstract][Full Text] [Related]
5. Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis. Zhao J; Li D; Tang H; Tang L Reprod Biol Endocrinol; 2020 Mar; 18(1):18. PubMed ID: 32164758 [TBL] [Abstract][Full Text] [Related]
6. Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies. Liao D; Yu H; Han L; Zhong C; Ran X; Wang D; Mo L J Endocrinol Invest; 2018 Nov; 41(11):1289-1300. PubMed ID: 29546656 [TBL] [Abstract][Full Text] [Related]
7. Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in southwest Chinese women. Wang Y; Liu H; Fan P; Bai H; Zhang J; Zhang F Eur J Endocrinol; 2012 May; 166(5):877-85. PubMed ID: 22301914 [TBL] [Abstract][Full Text] [Related]
8. European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus. Luo JQ; Ren H; Liu MZ; Fang PF; Xiang DX J Cell Mol Med; 2018 Mar; 22(3):1720-1732. PubMed ID: 29314660 [TBL] [Abstract][Full Text] [Related]
9. Association of vitamin D receptor gene variants with polycystic ovary syndrome: a meta-analysis. Shi XY; Huang AP; Xie DW; Yu XL BMC Med Genet; 2019 Feb; 20(1):32. PubMed ID: 30764792 [TBL] [Abstract][Full Text] [Related]
10. Paraoxonase single nucleotide variants show associations with polycystic ovary syndrome: a meta-analysis. Kunjantarachot A; Pabalan N; Jarjanazi H; Christofolini DM; Montagna E; Barbosa CP; Bianco B Reprod Biol Endocrinol; 2020 Nov; 18(1):114. PubMed ID: 33218342 [TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis. Lee YH; Kim JH; Seo YH; Choi SJ; Ji JD; Song GG Neurol Sci; 2015 Jan; 36(1):11-20. PubMed ID: 25301263 [TBL] [Abstract][Full Text] [Related]
12. Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome. Zhang Y; Liu H; He J; Xu K; Bai H; Wang Y; Zhang F; Zhang J; Cheng L; Fan P Eur J Endocrinol; 2015 Apr; 172(4):391-402. PubMed ID: 25575948 [TBL] [Abstract][Full Text] [Related]
13. PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women. Dadachanji R; Shaikh N; Patil A; Shah N; Mukherjee S Gene; 2018 Jun; 661():34-44. PubMed ID: 29604466 [TBL] [Abstract][Full Text] [Related]
14. Relationships between TCF7L2 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis. Shen WJ; Li TR; Hu YJ; Liu HB; Song M Metab Syndr Relat Disord; 2014 May; 12(4):210-9. PubMed ID: 24611738 [TBL] [Abstract][Full Text] [Related]
15. Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis. Nalkiran HS; Sahin SB; Ayaz T; Nalkiran I; Guzel AI; Eldes T; Yildiz Y Biomark Med; 2019 Mar; 13(4):279-289. PubMed ID: 30900463 [TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of the relationship between vitamin D receptor gene ApaI polymorphisms and polycystic ovary syndrome. Liang F; Ren N; Zhang H; Zhang J; Wu Q; Song R; Shi Z; Zhang Z; Wang K Adv Clin Exp Med; 2019 Feb; 28(2):255-262. PubMed ID: 30570841 [TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer. Xiong Y; Bian C; Lin X; Wang X; Xu K; Zhao X Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639550 [TBL] [Abstract][Full Text] [Related]
18. ADIPOQ gene polymorphisms and susceptibility to polycystic ovary syndrome: a HuGE survey and meta-analysis. Xian L; He W; Pang F; Hu Y Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):117-24. PubMed ID: 22239938 [TBL] [Abstract][Full Text] [Related]
19. Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression. Shen W; Li T; Hu Y; Liu H; Song M Gene; 2013 Dec; 531(2):426-34. PubMed ID: 23994294 [TBL] [Abstract][Full Text] [Related]
20. [The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome]. Zhang F; Liu HW; Fan P; Bai H; Song Q Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):24-8. PubMed ID: 21355294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]